IRIS Accounts Production v25.4.0.155 SC530639 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC5306392024-03-31SC5306392025-03-31SC5306392024-04-012025-03-31SC5306392023-03-31SC5306392023-04-012024-03-31SC5306392024-03-31SC530639ns15:Scotland2024-04-012025-03-31SC530639ns14:PoundSterling2024-04-012025-03-31SC530639ns10:Director12024-04-012025-03-31SC530639ns10:PrivateLimitedCompanyLtd2024-04-012025-03-31SC530639ns10:SmallEntities2024-04-012025-03-31SC530639ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-31SC530639ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-31SC530639ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-31SC530639ns10:FullAccounts2024-04-012025-03-31SC530639ns10:Director22024-04-012025-03-31SC530639ns10:RegisteredOffice2024-04-012025-03-31SC530639ns5:CurrentFinancialInstruments2025-03-31SC530639ns5:CurrentFinancialInstruments2024-03-31SC530639ns5:Non-currentFinancialInstruments2025-03-31SC530639ns5:Non-currentFinancialInstruments2024-03-31SC530639ns5:ShareCapital2025-03-31SC530639ns5:ShareCapital2024-03-31SC530639ns5:RetainedEarningsAccumulatedLosses2025-03-31SC530639ns5:RetainedEarningsAccumulatedLosses2024-03-31SC530639ns5:PlantMachinery2024-04-012025-03-31SC530639ns5:PlantMachinery2024-03-31SC530639ns5:PlantMachinery2025-03-31SC530639ns5:PlantMachinery2024-03-31SC530639ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-03-31SC530639ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2025-03-31SC530639ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-04-012025-03-31SC530639ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-03-31SC530639ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31SC530639ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31
REGISTERED NUMBER: SC530639 (Scotland)













FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

COSMEDICARE UK LIMITED

COSMEDICARE UK LIMITED (REGISTERED NUMBER: SC530639)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


COSMEDICARE UK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: Ms G G Baird
C S Gill MBE





REGISTERED OFFICE: 69 Barrachnie Road
Glasgow
LANARKSHIRE
G69 6NY





REGISTERED NUMBER: SC530639 (Scotland)





ACCOUNTANTS: Bannerman Johnstone Maclay
213 St Vincent Street
Glasgow
G2 5QY

COSMEDICARE UK LIMITED (REGISTERED NUMBER: SC530639)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,767,151 3,141,446

CURRENT ASSETS
Stocks 85,502 178,739
Debtors 5 3,023 29,223
Cash at bank 97,737 208,186
186,262 416,148
CREDITORS
Amounts falling due within one year 6 1,315,796 1,442,341
NET CURRENT LIABILITIES (1,129,534 ) (1,026,193 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,637,617

2,115,253

CREDITORS
Amounts falling due after more than one
year

7

(303,521

)

(535,946

)

PROVISIONS FOR LIABILITIES (449,790 ) (389,601 )
NET ASSETS 884,306 1,189,706

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 884,296 1,189,696
884,306 1,189,706

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

COSMEDICARE UK LIMITED (REGISTERED NUMBER: SC530639)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 December 2025 and were signed on its behalf by:





Ms G G Baird - Director


COSMEDICARE UK LIMITED (REGISTERED NUMBER: SC530639)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Cosmedicare UK Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 20% on cost and 10% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

COSMEDICARE UK LIMITED (REGISTERED NUMBER: SC530639)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include certain debtors and cash and bank balances, are initially measured at transaction price including transactions costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including certain creditors and loans from related undertakings, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


COSMEDICARE UK LIMITED (REGISTERED NUMBER: SC530639)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 42 (2024 - 48 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2024 3,867,889
Additions 10,522
At 31 March 2025 3,878,411
DEPRECIATION
At 1 April 2024 726,443
Charge for year 384,817
At 31 March 2025 1,111,260
NET BOOK VALUE
At 31 March 2025 2,767,151
At 31 March 2024 3,141,446

COSMEDICARE UK LIMITED (REGISTERED NUMBER: SC530639)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 April 2024 678,438
Transfer to ownership (174,143 )
At 31 March 2025 504,295
DEPRECIATION
At 1 April 2024 148,755
Charge for year 67,695
Transfer to ownership (56,596 )
At 31 March 2025 159,854
NET BOOK VALUE
At 31 March 2025 344,441
At 31 March 2024 529,683

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 3,023 29,223

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 152,667 152,667
Hire purchase contracts 79,150 98,327
Trade creditors 250,189 402,134
Amounts owed to group undertakings 50,000 50,000
Amounts owed to participating interests 200,108 192,842
Taxation and social security 14,001 19,813
Other creditors 569,681 526,558
1,315,796 1,442,341

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans 200,862 353,730
Hire purchase contracts 102,659 182,216
303,521 535,946

COSMEDICARE UK LIMITED (REGISTERED NUMBER: SC530639)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Monument (Scotland) Ltd.